Covidien Announces Continued Relationship with NYSE Euronext
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that Mallinckrodt plc intends to apply to list its ordinary shares on the New York Stock Exchange (NYSE) to trade under the symbol MNK.
As previously announced, Covidien plans to spin off its Pharmaceuticals business into Mallinckrodt, a stand-alone company, a process expected to be completed in mid-2013.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.